The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumLong Ideas - Wednesday morning, Catalyst Pharmaceutical Partners (NASDAQ:CPRX) announced that its previous guidance for top-line trial data at the end of September would be delayed until November. … Continue Reading
Read nowLong Ideas - Shares of ARIAD Pharmaceuticals (NASDAQ:ARIA) have been moving sporadically in the last week as traders test the limits of its latest range; ARIA set a … Continue Reading
Read nowLong Ideas - Novabay Pharmaceuticals (AMEX:NBY) could trade up today after the company announced the receipt of a $2.6M milestone payment from its development and marketing partner, Galderma … Continue Reading
Read nowLong Ideas - Sucampo Pharmaceuticals (NASDAQ:SCMP) announced with its partner Takeda Pharmaceuticals that the FDA has granted priority review for its sNDA (supplemental new drug application) for Amitiza … Continue Reading
Read nowInterviews - As the second-most prevalent cancer in the U.S. and 3rd leading cause of death, colorectal cancer and its treatment present a major market for Spectrum … Continue Reading
Read nowLong Ideas - Shares of Navidia Biopharmaceuticals (NASDAQ:NAVB) could trade higher today following a positive update from the company last night regarding the potential approval of lead product … Continue Reading
Read nowInterviews - Clinical trials and in-house drug development are expensive and time-consuming aspects of the biotechnology industry, but are nevertheless fixtures of standard business development. SciClone Pharmaceuticals … Continue Reading
Read now
